SpringWorks Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
64.50
|
|
Average Rating
|
4.43
|
|
# Strong Buys
|
3
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.32
|
-1.37
|
-0.05
|
-3.79%
|
|
2022-06-30
|
-1.20
|
-1.41
|
-0.21
|
-17.50%
|
|
2022-03-31
|
-1.02
|
-1.26
|
-0.24
|
-23.53%
|
|
2021-12-31
|
-0.88
|
-1.15
|
-0.27
|
-30.68%
|
|
2021-09-30
|
-0.76
|
-0.84
|
-0.08
|
-10.53%
|
|
2021-06-30
|
-0.67
|
-0.97
|
-0.30
|
-44.78%
|
|
2021-03-31
|
-0.51
|
-0.62
|
-0.11
|
-21.57%
|
|
2020-12-31
|
-0.10
|
0.30
|
0.40
|
400.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.04
|
|
2021-12-31
|
-3.58
|
|
2020-12-31
|
-1.05
|
|
2019-12-31
|
-2.59
|